Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma A Figtree

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
European Journal of Preventive Cardiology|December 17, 2025
Atherosclerosis risk in women with polycystic ovarian syndrome - it's not just the comorbiditiesKatharine Bate, Gemma A Figtree
The New England Journal of Medicine|June 19, 2009
Percutaneous coronary intervention versus coronary-artery bypass graftingRavinay Bhindi, Gemma A Figtree
Cardiovascular Research|May 26, 2021
Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveriesGemma A Figtree, Stephen T Vernon
Heart (British Cardiac Society)|September 16, 2025
Mammography-an opportunity to optimise women's heart health?Gemma A Figtree, Stuart M Grieve
Circulation|August 8, 2012
Letter by Ward and Figtree article, "mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease"Michael R Ward, Gemma A Figtree
Climacteric : the Journal of the International Menopause Society|May 16, 2025
Heart matters: the unique landscape of cardiovascular health in womenGemma A Figtree, Michael P Gray
The Medical Journal of Australia|October 8, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Gemma A Figtree
Resuscitation|September 27, 2022
Poorer care for the poor? Having fewer assets is associated with poorer care during, and worse outcomes after, an IHCASuzanne R Avis, Gemma A Figtree
European Heart Journal|June 7, 2024
Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yetGemma A Figtree, Michael P Gray
Circulation|January 15, 2019
Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"Gemma A Figtree, Karin Rådholm, Bruce Neal
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Preventive Cardiology|December 17, 2025
Atherosclerosis risk in women with polycystic ovarian syndrome - it's not just the comorbiditiesKatharine Bate, Gemma A Figtree
The New England Journal of Medicine|June 19, 2009
Percutaneous coronary intervention versus coronary-artery bypass graftingRavinay Bhindi, Gemma A Figtree
Cardiovascular Research|May 26, 2021
Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveriesGemma A Figtree, Stephen T Vernon
Heart (British Cardiac Society)|September 16, 2025
Mammography-an opportunity to optimise women's heart health?Gemma A Figtree, Stuart M Grieve
Circulation|August 8, 2012
Letter by Ward and Figtree article, "mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease"Michael R Ward, Gemma A Figtree
Climacteric : the Journal of the International Menopause Society|May 16, 2025
Heart matters: the unique landscape of cardiovascular health in womenGemma A Figtree, Michael P Gray
The Medical Journal of Australia|October 8, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Gemma A Figtree
Resuscitation|September 27, 2022
Poorer care for the poor? Having fewer assets is associated with poorer care during, and worse outcomes after, an IHCASuzanne R Avis, Gemma A Figtree
European Heart Journal|June 7, 2024
Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yetGemma A Figtree, Michael P Gray
Circulation|January 15, 2019
Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"Gemma A Figtree, Karin Rådholm, Bruce Neal
Pageof 26